This page lists all pharmaceutical reports related to the field of Cardiovascular Disorders. The reports include market research reports and pipeline analyses.
Displaying 1 - 50 of 177 results
- Biomarkers: A Market Briefing
- Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Medical Imaging Markets: Radiography
- The Global Market for Adjunctive Therapies in Cancer
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- Diabetes and Diabetic Complications: Major World Markets
- Nitric Oxide - Therapeutics, Markets and Companies
- Cardiovascular Drug Delivery - technologies,markets and companies
- Cardiac Marker Diagnostic Testing Markets
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Stem Cell Markets
- Hematology Analyzer Instrumentation and Reagent Markets
- The World Hypertension Market 2005-2010
- Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
- The Cardiovascular Market Outlook to 2011
- Early Toxicology: Markets and Approaches
- Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Antithrombotics - Pipeline products to dampen the impact of patent expiries and cost containment initiatives
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook
- Antihypertensives - New challenges for a maturing market
- From Blockbuster to Nichebuster
- Pipeline Insight: Antiarrhythmics - RSD1235 in a class of its own
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Pipeline Insight: Antihypertensives - Weak pipeline leaves innovation to Novartis
- Pulmonary Arterial Hypertension - A small market gets big attention
- Drug Treatment in End-Stage Renal Disease
- Therapeutic Vaccines
- Antihypertensives - Two Years to Shape the Market?
- Hypertension - Multiple Layers of Therapy Cover all Eventualities
- Chronic and Acute Heart Failure
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Dyslipidemia - Statins Dominate Treatment Pathway
- Pipeline Insight: Antithrombotics - Anticoagulants and Antiplatelets Have Blockbuster Potential
- Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
- Stakeholder Insight: Heart Failure
- Stakeholder Insight: Acute Stroke
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Pipeline Insight: Acute Stroke - Considerable unmet need is balanced by substantial commercial risk
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Cell-Based Assays for Drug Discovery
- Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
- Personalized Medicine
- Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges